Abstract.-A cell-free system allowing for synthesis of 13-galactosidase enzymatic activity has been developed. This system requires DNA containing the f3-galactosidase gene, a cell-free extract of Escherichia coli bacteria, and the lowmolecular-weight components necessary for transcription of the DNA and translation of the resulting messenger RNA. Such a system is useful for studying enzyme synthesis, as well as its regulation. The gene for f3-galactosidase is part of the lac operon whose expression is under the control of the lac repressor. In whole cells the lac repressor inhibits almost all of the gene expression for ,3-galactosidase. In the cell-free system, we had previously been able to repress about half the gene expression. Adding cyclic adenosine 3'5'-monophosphate to the cell-free system improved the yield of ,3-galactosidase enzymatic activity by 8 to 30 times and the efficiency of repression from 50 to 95 per cent.
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Introduction.-A DNA-directed cell-free system capable of producing ,3-galactosidase activity has been reported. [1] [2] [3] This system requires the presence of DNA containing the gene for f-galactosidase, a cell-free extract of E. coli bacteria, and the low-molecular-weight components necessary for transcription of the DNA and translation of the resulting mRNA. Conditions can be varied such that it is necessary to synthesize only the first quarter of the f3-galactosidase peptide chain, termed a, to obtain enzyme activity.1' 2 This synthesis is accomplished through use of a cell-free extract from a mutant E. coli strain containing M15 protein, a defective 3-galactosidase that complements with the newly formed a to give the active enzyme. Complementation between a and M15 protein occurs concomitantly with the synthesis of a.4 Synthesis of the active enzyme can also be made to occur in the absence of Mi15 protein or other complement of aC.3 In this case, the entire enzymatically active polypeptide must be synthesized de novo by the cell-free system. In addition to examination of the unrepressed synthesis of a and whole ,B-galactosidase, studies of the inhibition of a synthesis by lac repressor have been made.2 5 The lac repressor, which must be present at the start of synthesis, was supplied in one of two ways: either it was a normal component of the bacterial strain from which the cell-free extract was made, or, where strains contain no endogenous repressor, it was added in a partially purified concentrated form. Partial inhibition of a synthesis was observed in the presence of the lac repressor, and this inhibition could be overcome by addition of isopropyl-l-thio-j3-D-galactopyranoside, a strong inducer of the lac operon.2 I These observations of repression and derepression are in qualitative agreement with the chemical behavior of the lac system in whole cells. It seems likely that the inhibiting effect of the repressor 118 on the synthesis of a is due to the binding of the repressor to the lac operator, as postulated by Jacob and M\lonod. 6 Heretofore, only about half the synthesis of a was repressible in the cellfree system.2 5 Attempts have been made to optimize conditions, both for the gross amount of enzyme synthesis and for the effectiveness of repression. In the present study, we report the effect of the addition of cyclic adenosine 3'5'-monophosphate (3'5'-AMIP) to the cell-free system. This compound produces a dramatic increase in the total synthesis of the enzyme, as well as in the effectiveness of repression. We were led to test the effect of 3'5'-AMP in the cellfree system by the report of Pearlman and Pastan that the compound stimulates f3-galactosidase synthesis in whole cells.7
Results and Discussion.-Description of the cell-free system and assays: The details involved in synthesis of partial and total enzyme activity have been described elsewhere.'-', 8 Usually all ingredients except the cell-free bacterial extract (S-30) are mixed in the cold and then preincubated at 370C for three minutes. The S-30 is added to the mix and incubated at 370C for one hour with mild shaking. After this time, an aliquot is removed and assayed for,-galactosidase activity. In experiments where gross RNA or peptide synthesis was measured, 14C-ATP or '4C-leucine, respectively, was added at the start of synthesis. RNA synthesis was assayed by measuring radioactive incorporation into the cold trichloroacetic acid precipitate; to observe peptide synthesis, the hot trichloroacetic acid insoluble precipitate was measured in a similar fashion. The S-30 extracts used in these studies were prepared from three different E. coli strains: Zj9iq, Z19i-, and 514 (described in detail elsewhere3 5). Zj9iq contains the repressor gene iq and the M15 #3-galactosidase gene on both chromosome and episome. Strain Z19i-is identical to Zj9iq, except that it does not contain a lac repressor gene. Strain 514 contains a deletion of the entire region occupied by the lac operon and the gene for lac repressor. DNA was obtained from the 480dlac virus.
Effect of 3'5'-AMP on enzyme synthesis: It was first noted that 3'5'-AMP has a beneficial effect on a synthesis with S-30 extracts prepared from strain Z19i-. The concentration dependence of the effect (see Figure 1 ) showed a broad optimum above 0.5 mM 3'5'-AM\IP. In subsequent studies, 3'5'-AMP was used at a concentration of 1 mM. It must be added before the start of synthesis. No effect was obtained if the compound was added after synthesis, nor could adenosine 2'-monophosphate, adenosine 3'-monophosphate, or cyclic adenosine 2'3'-monophosphate substitute for 3'5'-AMP.
The presence of 3'5'-AMP improved the observed amount of enzyme synthesis by from 8 to 13 times when S-30's from strains Z19i-or Zj9iq were used (see Figures 1 and 2 ). With Zj9iq, 5 X 10-5 M of isopropyl-l-thio-B-D-galactopyranoside inducer must be present to derepress the system. It should be noted that both these strains contain the a complement. 3'5'-AMP improved the observed enzymatic activity 20-to 30-fold when strain 514 was used to prepare the S-30 (see Figure 2) . Since has always been obtained with S-30's prepared from a-complementing strains than from lac deletion strains such as 514 (for example, see Fig. 2 and ref. 3 ). This attests to the efficacy of the complementation process. The data of Figure 2 suggest that in the presence of 3'5'-AMP this situation is reversed.
Our tentative explanation for the reversal is that in the noncomplementing system in the presence of 3'5'-AMP, many more complete chains of j3-galactosi- (0) refers to the synthetic system in which S-30 extract is prepared from strain 514.
(X) refers to the synthetic system in which S-30 extract is prepared from strain Z19iq.
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dase polypeptide are made with a higher specific activity than that of the enzyme produced by a complementation. The amount of enzyme activity obtained with S-30 extract prepared from strain 514 (Fig. 2) was equivalent to 25 X 10-9 gm/ml of f3-galactosidase. In a parallel experiment, it was found that 2.5 mjumoles of leucine were incorporated This study represents the first time it has been shown to be directly involved in the cell-free process of RNA and protein synthesis. We feel that an understanding of the effect of 3'5'-AMP in this system will be most valuable for the elucidation of mechanisms in cell synthesizing systems.
Note added in proof: Makman and Sutherland (J. Biol. Chem., 240, 1309 (1965)) have shown that a rise in cyclic AMP occurs as the glucose level decreases in a growing culture of E. coli. This observation, coupled with the results presented here, leads us to the working hypothesis that cylic AMP triggers the synthesis of catabolite enzymes such as j3-galactosidase. We are currently investigating the possibility that the primary action of cyclic AMP is on the RNA polymerase.
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